General Information of the Compound
| Compound ID |
CP0861144
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(R)-5-benzyl-3-((R)-1-(4-fluorophenyl)ethyl)-5-(5-(pyridin-3-yl)-1H-benzo[d]imidazol-2-yl)oxazolidine-2,4-dione
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C30H23FN4O3
|
||||||||||||||||||
| Molecular Weight |
506.537
|
||||||||||||||||||
| Canonical SMILES |
C[C@H](c1ccc(F)cc1)N1C(=O)O[C@](Cc2ccccc2)(c2nc3cc(-c4cccnc4)ccc3[nH]2)C1=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C30H23FN4O3/c1-19(21-9-12-24(31)13-10-21)35-28(36)30(38-29(35)37,17-20-6-3-2-4-7-20)27-33-25-14-11-22(16-26(25)34-27)23-8-5-15-32-18-23/h2-16,18-19H,17H2,1H3,(H,33,34)/t19-,30-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
QZHFQEFAPKPMGA-HZAQMHFWSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00894, Androgen receptor
Protein ID: PT00886, Estrogen receptor
Protein ID: PT00967, Glucocorticoid receptor
Protein ID: PT01154, Mineralocorticoid receptor
Protein ID: PT01172, Progesterone receptor